Related Experiment Video
Updated: Jul 31, 2026
10:37
Ferric Chloride-induced Murine Thrombosis Models
Published on: September 5, 2016
Ceruloplasmin and cardiovascular disease
P L Fox1, B Mazumder, E Ehrenwald
1Department of Cell Biology, The Lerner Research Institute, Cleveland Clinic Foundation, Cleveland, OH 44195, USA. foxp@ccf.org
Free Radical Biology & Medicine
|August 18, 2000
Summary
Ceruloplasmin (Cp), a copper-containing protein, is a potent catalyst for low-density lipoprotein (LDL) oxidation, independent of free metal ions. This finding is crucial for understanding cardiovascular disease risk factors.
Area of Science:
- Biochemistry
- Cardiovascular Science
- Oxidative Stress Research
Background:
- Transition metal ion-mediated oxidation is a common model for low-density lipoprotein (LDL) modification.
- The physiological relevance of free metal ions in LDL oxidation is uncertain.
- Human ceruloplasmin (Cp) is a key copper-containing serum protein with potential roles in oxidative processes.
Purpose of the Study:
- To investigate the role of human ceruloplasmin (Cp) in LDL oxidation, independent of free metal ions.
- To explore Cp's catalytic activity and structural requirements for LDL oxidation.
- To assess the contribution of Cp to LDL oxidation by various cell types.
Main Methods:
- Biochemical assays to measure LDL oxidation catalyzed by Cp.
- Structural analysis to identify key residues and cofactors involved in Cp's activity.
- Cell culture experiments using endothelial, smooth muscle, and monocytic cells to study LDL oxidation.
- Inhibitor studies using Cp-specific antibodies and antisense oligonucleotides.
Main Results:
- Cp is a potent catalyst of LDL oxidation in vitro, requiring an intact structure and a surface-bound copper atom.
- Cp-mediated LDL oxidation is optimal in the presence of superoxide and can be inhibited by proteins like albumin.
- Vascular cells oxidize LDL via Cp, with superoxide release being critical.
- Monocytic cells secrete Cp and contribute significantly to LDL oxidation.
Conclusions:
- Ceruloplasmin (Cp) is a significant factor in LDL oxidation, independent of free metal ions.
- Cp's pro-oxidant activity is linked to its copper content and structural integrity.
- Cp plays a role in cellular LDL oxidation, particularly in monocytic cells, highlighting its potential involvement in cardiovascular disease pathogenesis.
Related Concept Videos
01:30Anticoagulant Drugs: Low-Molecular-Weight Heparins
Hemostasis is a crucial process that prevents excessive blood loss from damaged blood vessels. It involves various mechanisms such as vasoconstriction, platelet adhesion and activation, and fibrin formation. The importance of each mechanism depends on the type of vessel injury. In contrast, thrombosis is the abnormal formation of a blood clot within the blood vessels, leading to potential complications if the clot obstructs blood flow. Thrombosis can be caused by increased coagulability of the...
01:24Disorders of Hemostasis
Hemostasis, the process that stops bleeding after a blood vessel injury, is crucial for maintaining the integrity of the circulatory system. However, disorders of hemostasis can disrupt this delicate balance, leading to either excessive clotting or bleeding. These disorders can be broadly classified into thromboembolic disorders and bleeding disorders.
Thromboembolic Disorders
Two factors primarily cause thromboembolic conditions.
Thromboembolic Disorders
Two factors primarily cause thromboembolic conditions.
01:19Blood Studies for Cardiovascular System II: CRP, Hcy, and Cardiac Natriuretic Peptide Markers
Cardiac biomarkers are critical in diagnosing, prognosing, and managing cardiovascular diseases. Routine measurement of specific biomarkers such as B-type natriuretic peptide (BNP), C-reactive protein (CRP), and homocysteine (Hcy) is common practice in clinical settings to evaluate heart function and predict cardiovascular events.
These markers indicate stress or strain on the heart muscle:
Natriuretic Peptides (BNP)
Cardiac myocytes produce these hormones in response to ventricular stretching...
These markers indicate stress or strain on the heart muscle:
Natriuretic Peptides (BNP)
Cardiac myocytes produce these hormones in response to ventricular stretching...
01:29Cardiomyopathy IV: Restrictive Cardiomyopathy
Restrictive cardiomyopathy (RCM) is a rare heart muscle disease characterized by impaired ventricular filling due to stiffened ventricular walls, leading to significant diastolic dysfunction.EtiologyRestrictive cardiomyopathy can arise from both inherited and acquired diseases, many of which are systemic. It is categorized into four main types: infiltrative, storage, non-infiltrative, and endomyocardial diseases.Infiltrative diseases, such as amyloidosis, lead to RCM by depositing amyloid...
01:27Psychoneuroimmunology: Cardiovascular Disease
Psychoneuroimmunology (PNI) is a multidisciplinary field that examines how psychological factors, particularly stress, interact with the immune system and impact physical health. Research in PNI has shown that chronic or traumatic stress can disrupt both the hypothalamic-pituitary-adrenal axis and the sympathetic nervous system. These disruptions contribute to serious health conditions, including cardiovascular diseases.
A key area of focus in PNI is the relationship between stress and coronary...
A key area of focus in PNI is the relationship between stress and coronary...
01:25Jaundice
Jaundice, or icterus, is the yellow discoloration of the skin, sclerae, and mucous membranes. It happens when plasma bilirubin levels rise above 2.5-3 mg/dL, leading to bilirubin deposition in tissue.Bilirubin is a byproduct of hemoglobin degradation. In macrophages, hemoglobin breaks down into globin and heme. Globin is converted into amino acids, while heme is turned into biliverdin by heme oxygenase, which is then reduced to unconjugated bilirubin by biliverdin reductase.Unconjugated...